1. From the Department of Immunology, Division of Investigative Science, Faculty of Medicine, Imperial College of Science, Technology and Medicine, The Chelsea and Westminster Hospital, London; the Department of Infectious Diseases, Division of Investigative Science, Faculty of Medicine, Imperial College at Hammersmith Hospital, London, United Kingdom; and the Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut School of Medicine, Farmington.